feed,title,long_url,short_url
Benzinga,Bluebird Bio Temporarily Suspends Sickle Cell Gene Therapy Studies Following Incidences of Blood Cancer,https://www.benzinga.com/general/biotech/21/02/19674197/bluebird-bio-temporarily-suspends-sickle-cell-gene-therapy-studies-following-incidences-of-blood-,https://j.mp/3rWRovs
